Compile Data Set for Download or QSAR
maximum 50k data
Found 404 with Last Name = 'riemer' and Initial = 'c'
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
F. Hoffmann-La Roche

Curated by ChEMBL
LigandPNGBDBM50001524(CHEMBL24474)
Affinity DataKi:  0.110nMAssay Description:Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 6 receptor expressed in HeLa cells using [3H]LSD as radioligandChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233239(US9346786, 43)
Affinity DataKi:  0.300nM ΔG°:  -50.5kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233309(US9346786, 113)
Affinity DataKi:  0.5nM ΔG°:  -49.3kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233255(US9346786, 59)
Affinity DataKi:  0.5nM ΔG°:  -49.3kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233312(US9346786, 116)
Affinity DataKi:  0.5nM ΔG°:  -49.3kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233237(US9346786, 41)
Affinity DataKi:  0.600nM ΔG°:  -48.9kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
F. Hoffmann-La Roche

Curated by ChEMBL
LigandPNGBDBM50329161((3R,4S)-3-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-...)
Affinity DataKi:  0.600nMAssay Description:Displacement of [3H]substance P from human neurokinin NK1 receptor expressed in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A2a(Homo sapiens (Human))
F. Hoffmann-La Roche

Curated by ChEMBL
LigandPNGBDBM50048466(2-(furan-2-yl)-7-phenethyl-7H-pyrazolo[4,3-e][1,2,...)
Affinity DataKi:  0.600nMAssay Description:Binding affinity against human Adenosine A2a receptor (hA2a)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233253(US9346786, 57)
Affinity DataKi:  0.700nM ΔG°:  -48.6kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233236(US9346786, 40)
Affinity DataKi:  0.700nM ΔG°:  -48.6kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233259(US9346786, 63)
Affinity DataKi:  0.700nM ΔG°:  -48.6kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233308(US9346786, 112)
Affinity DataKi:  0.800nM ΔG°:  -48.3kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
F. Hoffmann-La Roche

Curated by ChEMBL
LigandPNGBDBM21190(4-(2-{[5-amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-...)
Affinity DataKi:  0.800nMAssay Description:Binding affinity against human Adenosine A2a receptor (hA2a)More data for this Ligand-Target Pair
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233257(US9346786, 61)
Affinity DataKi:  0.800nM ΔG°:  -48.3kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
F. Hoffmann-La Roche

Curated by ChEMBL
LigandPNGBDBM50329160(2-(3,5-bis(trifluoromethyl)phenyl)-N-((3R,4S)-4-(4...)
Affinity DataKi:  0.900nMAssay Description:Displacement of [3H]substance P from human neurokinin NK1 receptor expressed in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233311(US9346786, 115)
Affinity DataKi:  0.900nM ΔG°:  -48.0kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233242(US9346786, 46)
Affinity DataKi:  1nM ΔG°:  -47.8kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
F. Hoffmann-La Roche

Curated by ChEMBL
LigandPNGBDBM50228649(4-(2-Bromo-6-pyrrolidin-1-yl-pyridine-4-sulfonyl)-...)
Affinity DataKi:  1nMAssay Description:Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 6 receptor expressed in HeLa cells using [3H]LSD as radioligandChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233262(US9346786, 66)
Affinity DataKi:  1nM ΔG°:  -47.8kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233197(US9346786, 1 | US9346786, 5)
Affinity DataKi:  1nM ΔG°:  -47.8kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
F. Hoffmann-La Roche

Curated by ChEMBL
LigandPNGBDBM50329162((3R,4S)-3-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-...)
Affinity DataKi:  1.10nMAssay Description:Displacement of [3H]substance P from human neurokinin NK1 receptor expressed in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
F. Hoffmann-La Roche

Curated by ChEMBL
LigandPNGBDBM50329163(CHEMBL1269639 | N-((3R,4S)-1-(4-acetylpiperazine-1...)
Affinity DataKi:  1.40nMAssay Description:Displacement of [3H]substance P from human neurokinin NK1 receptor expressed in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233310(US9346786, 114)
Affinity DataKi:  1.60nM ΔG°:  -46.7kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233305(US9346786, 109)
Affinity DataKi:  1.70nM ΔG°:  -46.5kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233316(US9346786, 120)
Affinity DataKi:  1.70nM ΔG°:  -46.5kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233314(US9346786, 118)
Affinity DataKi:  1.80nM ΔG°:  -46.4kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
F. Hoffmann-La Roche

Curated by ChEMBL
LigandPNGBDBM50147665(CHEMBL112773 | [5-Amino-2-(5-bromo-furan-2-yl)-[1,...)
Affinity DataKi:  2nMAssay Description:Binding affinity against human Adenosine A2a receptor (hA2a)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A2a(Homo sapiens (Human))
F. Hoffmann-La Roche

Curated by ChEMBL
LigandPNGBDBM50147656(CHEMBL113967 | [5-Amino-2-(5-bromo-furan-2-yl)-[1,...)
Affinity DataKi:  2nMAssay Description:Binding affinity against human Adenosine A2a receptor (hA2a)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233238(US9346786, 42)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233240(US9346786, 44)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233247(US9346786, 51)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233212(US9346786, 16)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233197(US9346786, 1 | US9346786, 5)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233213(US9346786, 17)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233214(US9346786, 18)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233243(US9346786, 47)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233263(US9346786, 67)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233264(US9346786, 68)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233265(US9346786, 69)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233268(US9346786, 72)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233217(US9346786, 21)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233244(US9346786, 48)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233276(US9346786, 80)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233283(US9346786, 87)
Affinity DataKi:  2.10nM ΔG°:  -46.0kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
F. Hoffmann-La Roche

Curated by ChEMBL
LigandPNGBDBM50329164(2-(3,5-bis(trifluoromethyl)phenyl)-N-((3R,4S)-4-(4...)
Affinity DataKi:  2.10nMAssay Description:Displacement of [3H]substance P from human neurokinin NK1 receptor expressed in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
F. Hoffmann-La Roche

Curated by ChEMBL
LigandPNGBDBM50001523(CHEMBL23575)
Affinity DataKi:  2.30nMAssay Description:Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 6 receptor expressed in HeLa cells using [3H]LSD as radioligandChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233286(US9346786, 90)
Affinity DataKi:  2.40nM ΔG°:  -45.7kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233271(US9346786, 75)
Affinity DataKi:  3nM ΔG°:  -45.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM233261(US9346786, 65)
Affinity DataKi:  3nM ΔG°:  -45.2kJ/molepH: 7.4 T: 2°CAssay Description:hNK3 receptor binding experiment were performed using [3H]SR142801 (Catalog No. TRK1035, specific activity: 74.0 Ci/mmol, Amersham, GE Healthcare UK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
F. Hoffmann-La Roche

Curated by ChEMBL
LigandPNGBDBM50147655(CHEMBL323945 | [5-Amino-2-(5-bromo-furan-2-yl)-[1,...)
Affinity DataKi:  3nMAssay Description:Binding affinity against human Adenosine A2a receptor (hA2a)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 404 total ) | Next | Last >>
Jump to: